{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T22:30:40Z","timestamp":1771367440605,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,17]]},"DOI":"10.7759\/cureus.103788","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T21:49:55Z","timestamp":1771364995000},"source":"Crossref","is-referenced-by-count":0,"title":["Cholangiocarcinoma: Is Preoperative Histologic Confirmation Mandatory Before Major Hepatobiliary Surgery?"],"prefix":"10.7759","author":[{"given":"Sergio Isidro","family":"Gamboa-Hoil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2016.51","article-title":"Expert consensus document. Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)","volume":"13","author":"Banales JM","year":"2016","unstructured":"Banales JM, Cardinale V, Carpino G, et al.. Expert consensus document. Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol. 2016, 13:261-80. 10.1038\/nrgastro.2016.51","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref2","article-title":"Cholangiocarcinoma","author":"Menon G","year":"2024","unstructured":"Menon G, Garikipati SC, Roy P. Cholangiocarcinoma. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.10.506","article-title":"Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Vogel A","year":"2023","unstructured":"Vogel A, Bridgewater J, Edeline J, et al.. Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023, 34:127-40. 10.1016\/j.annonc.2022.10.506","journal-title":"Ann Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-024-03596-y","article-title":"Resectability and survival outcome in real world practice of 720 cholangiocarcinoma patients: intrahepatic, perihilar and distal cholangiocarcinoma","volume":"22","author":"Sarkhampee P","year":"2024","unstructured":"Sarkhampee P, Ouransatien W, Lertsawatvicha N, Chansitthichock S, Wattanarath P. Resectability and survival outcome in real world practice of 720 cholangiocarcinoma patients: intrahepatic, perihilar and distal cholangiocarcinoma. World J Surg Oncol. 2024, 22:314. 10.1186\/s12957-024-03596-y","journal-title":"World J Surg Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/1756284820927292","article-title":"Challenging biliary strictures: pathophysiological features, differential diagnosis, diagnostic algorithms, and new clinically relevant biomarkers - part 1","volume":"13","author":"Dumonceau JM","year":"2020","unstructured":"Dumonceau JM, Delhaye M, Charette N, Farina A. Challenging biliary strictures: pathophysiological features, differential diagnosis, diagnostic algorithms, and new clinically relevant biomarkers - part 1. Therap Adv Gastroenterol. 2020, 13:1756284820927292. 10.1177\/1756284820927292","journal-title":"Therap Adv Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2016.03.035","article-title":"Postoperative mortality after liver resection for perihilar cholangiocarcinoma: development of a risk score and importance of biliary drainage of the future liver remnant","volume":"223","author":"Wiggers JK","year":"2016","unstructured":"Wiggers JK, Groot Koerkamp B, Cieslak KP, et al.. Postoperative mortality after liver resection for perihilar cholangiocarcinoma: development of a risk score and importance of biliary drainage of the future liver remnant. J Am Coll Surg. 2016, 223:321-31.e1. 10.1016\/j.jamcollsurg.2016.03.035","journal-title":"J Am Coll Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.hpb.2019.07.003","article-title":"Left- versus right-sided hepatectomy with hilar en-bloc resection in perihilar cholangiocarcinoma","volume":"22","author":"Bednarsch J","year":"2020","unstructured":"Bednarsch J, Czigany Z, Lurje I, et al.. Left- versus right-sided hepatectomy with hilar en-bloc resection in perihilar cholangiocarcinoma. HPB (Oxford). 2020, 22:437-44. 10.1016\/j.hpb.2019.07.003","journal-title":"HPB (Oxford)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1663334","article-title":"Right-side versus left-side hemihepatectomy for the treatment of Bismuth type IV perihilar cholangiocarcinoma: a comparative study","volume":"15","author":"Ma W","year":"2025","unstructured":"Ma W, Hu M, Xie Z, et al.. Right-side versus left-side hemihepatectomy for the treatment of Bismuth type IV perihilar cholangiocarcinoma: a comparative study. Front Oncol. 2025, 15:1663334. 10.3389\/fonc.2025.1663334","journal-title":"Front Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70491","article-title":"Impact of clinical characteristics and treatment on cholangiocarcinoma prognosis in southern Thailand","volume":"13","author":"Sathitruangsak C","year":"2024","unstructured":"Sathitruangsak C, Pattarapuntakul T, Kaewdech A, et al.. Impact of clinical characteristics and treatment on cholangiocarcinoma prognosis in southern Thailand. Cancer Med. 2024, 13:e70491. 10.1002\/cam4.70491","journal-title":"Cancer Med"},{"key":"ref10","article-title":"Update on the screening, diagnosis, and management of cholangiocarcinoma","volume":"20","author":"Kodali S","year":"2024","unstructured":"Kodali S, Connor AA, Brombosz EW, Ghobrial RM. Update on the screening, diagnosis, and management of cholangiocarcinoma. Gastroenterol Hepatol (N Y). 2024, 20:151-8.","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2025.03.007","article-title":"EASL Clinical Practice Guidelines on the management of extrahepatic cholangiocarcinoma","volume":"83","author":"European Association for the Study of the Liver","year":"2025","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the management of extrahepatic cholangiocarcinoma. J Hepatol. 2025, 83:211-38. 10.1016\/j.jhep.2025.03.007","journal-title":"J Hepatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16111946","article-title":"Cholangiocarcinoma: the current status of surgical options including liver transplantation","volume":"16","author":"Esmail A","year":"2024","unstructured":"Esmail A, Badheeb M, Alnahar B, et al.. Cholangiocarcinoma: the current status of surgical options including liver transplantation. Cancers (Basel). 2024, 16:1946. 10.3390\/cancers16111946","journal-title":"Cancers (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14176028","article-title":"Advances in endoscopic diagnosis and management of cholangiocarcinoma","volume":"14","author":"Chaudhary U","year":"2025","unstructured":"Chaudhary U, Shah SL. Advances in endoscopic diagnosis and management of cholangiocarcinoma. J Clin Med. 2025, 14:6028. 10.3390\/jcm14176028","journal-title":"J Clin Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.54.6.449","article-title":"Brush cytology in the assessment of pancreatico-biliary strictures: a review of 406 cases","volume":"54","author":"Stewart CJ","year":"2001","unstructured":"Stewart CJ, Mills PR, Carter R, O'Donohue J, Fullarton G, Imrie CW, Murray WR. Brush cytology in the assessment of pancreatico-biliary strictures: a review of 406 cases. J Clin Pathol. 2001, 54:449-55. 10.1136\/jcp.54.6.449","journal-title":"J Clin Pathol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2016.05.001","article-title":"Detection of benign hilar bile duct stenoses - a retrospective analysis in 250 patients with suspicion of Klatskin tumour","volume":"8","author":"Scheuermann U","year":"2016","unstructured":"Scheuermann U, Widyaningsih R, Hoppe-Lotichius M, Heise M, Otto G. Detection of benign hilar bile duct stenoses - a retrospective analysis in 250 patients with suspicion of Klatskin tumour. Ann Med Surg (Lond). 2016, 8:43-9. 10.1016\/j.amsu.2016.05.001","journal-title":"Ann Med Surg (Lond)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/13651820801992633","article-title":"Is preoperative histological diagnosis necessary for cholangiocarcinoma?","volume":"10","author":"Davidson BR","year":"2008","unstructured":"Davidson BR, Gurusamy K. Is preoperative histological diagnosis necessary for cholangiocarcinoma?. HPB (Oxford). 2008, 10:94-7. 10.1080\/13651820801992633","journal-title":"HPB (Oxford)"},{"key":"ref17","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Biliary Tract Cancers. Version 2.2025. (2025). Accessed: February 15, 2026: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&amp;id=1517."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199911000-00008","article-title":"Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection","volume":"230","author":"Kosuge T","year":"1999","unstructured":"Kosuge T, Yamamoto J, Shimada K, Yamasaki S, Makuuchi M. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg. 1999, 230:663-71. 10.1097\/00000658-199911000-00008","journal-title":"Ann Surg"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-001-0110-8","article-title":"Complications of hepatectomy for hilar cholangiocarcinoma","volume":"25","author":"Nagino M","year":"2001","unstructured":"Nagino M, Kamiya J, Uesaka K, et al.. Complications of hepatectomy for hilar cholangiocarcinoma. World J Surg. 2001, 25:1277-83. 10.1007\/s00268-001-0110-8","journal-title":"World J Surg"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-024-15115-0","article-title":"Higher postoperative mortality and inferior survival after right-sided liver resection for perihilar cholangiocarcinoma: left-sided resection is preferred when possible","volume":"31","author":"Olthof PB","year":"2024","unstructured":"Olthof PB, Erdmann JI, Alikhanov R, et al.. Higher postoperative mortality and inferior survival after right-sided liver resection for perihilar cholangiocarcinoma: left-sided resection is preferred when possible. Ann Surg Oncol. 2024, 31:4405-12. 10.1245\/s10434-024-15115-0","journal-title":"Ann Surg Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2015.04.007","article-title":"Major hepatectomies for perihilar cholangiocarcinoma: predictors for clinically relevant postoperative complications using the International Study Group of Liver Surgery definitions","volume":"39","author":"Dumitrascu T","year":"2016","unstructured":"Dumitrascu T, Brasoveanu V, Stroescu C, Ionescu M, Popescu I. Major hepatectomies for perihilar cholangiocarcinoma: predictors for clinically relevant postoperative complications using the International Study Group of Liver Surgery definitions. Asian J Surg. 2016, 39:81-9. 10.1016\/j.asjsur.2015.04.007","journal-title":"Asian J Surg"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/s1479-666x(03)80006-9","article-title":"Incidence of benign pathology in patients undergoing hepatic resection for suspected malignancy","volume":"1","author":"Clayton R","year":"2003","unstructured":"Clayton R, Clarke D, Currie E, Madhavan KK, Parks RW, Garden OJ. Incidence of benign pathology in patients undergoing hepatic resection for suspected malignancy. Surgeon. 2003, 1:32-8. 10.1016\/s1479-666x(03)80006-9","journal-title":"Surgeon"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/BF01655714","article-title":"Surgical treatment of carcinoma of the hepatic duct confluence: analysis of 55 resected carcinomas","volume":"17","author":"Ogura Y","year":"1993","unstructured":"Ogura Y, Mizumoto R, Tabata M, Matsuda S, Kusuda T. Surgical treatment of carcinoma of the hepatic duct confluence: analysis of 55 resected carcinomas. World J Surg. 1993, 17:85-92; discussion 92-3. 10.1007\/BF01655714","journal-title":"World J Surg"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.3.947","article-title":"Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors","volume":"15","author":"Klempnauer J","year":"1997","unstructured":"Klempnauer J, Ridder GJ, von Wasielewski R, Werner M, Weimann A, Pichlmayr R. Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol. 1997, 15:947-54. 10.1200\/JCO.1997.15.3.947","journal-title":"J Clin Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s12893-025-03374-x","article-title":"Characteristics of late recurrences after hepatectomy for perihilar cholangiocarcinoma: a single-center cohort study","volume":"26","author":"Sato H","year":"2026","unstructured":"Sato H, Aoki S, Iseki M, et al.. Characteristics of late recurrences after hepatectomy for perihilar cholangiocarcinoma: a single-center cohort study. BMC Surg. 2026, 26:109. 10.1186\/s12893-025-03374-x","journal-title":"BMC Surg"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/BF01658686","article-title":"Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus","volume":"14","author":"Nimura Y","year":"1990","unstructured":"Nimura Y, Hayakawa N, Kamiya J, Kondo S, Shionoya S. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg. 1990, 14:535-43; discussion 544. 10.1007\/BF01658686","journal-title":"World J Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/465980-cholangiocarcinoma-is-preoperative-histologic-confirmation-mandatory-before-major-hepatobiliary-surgery","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T21:49:57Z","timestamp":1771364997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/465980-cholangiocarcinoma-is-preoperative-histologic-confirmation-mandatory-before-major-hepatobiliary-surgery"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.103788","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,17]]}}}